ArticleOncoimmunology

PD-1 blockade at the time of tumor escape potentiates the immune-mediated antitumor effects of a melanoma-targeting monoclonal antibody.

Laetitia They et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.